Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 29, Issue 2, 2016, Pages 127-133

  Leach, Chet L ^a   Kuehl, Philip J ^a   Chand, Ramesh ^a   McDonald, Jacob D ^a  

^a Lovelace Resp Research Institute   (Mexico)

Author keywords

aerosol distribution; Clinical trial; Inhaled therapy; Metered dose inhaler; Scintigraphy

Indexed keywords

BECLOMETASONE DIPROPIONATE; FLUTICASONE PROPIONATE; TECHNETIUM 99M; AEROSOL; ANTIASTHMATIC AGENT; BECLOMETASONE; BRONCHODILATING AGENT; FLUORINATED HYDROCARBON; FLUTICASONE; PROPELLANT;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CROSSOVER PROCEDURE; HUMAN; MALE; MIDDLE AGED; OPEN STUDY; OROPHARYNX; PARTICLE SIZE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; YOUNG ADULT; AEROSOL; CHEMISTRY; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; DRUG FORMULATION; INHALATIONAL DRUG ADMINISTRATION; LUNG; METABOLISM; METERED DOSE INHALER; MULTIMODAL IMAGING; PROCEDURES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; X-RAY COMPUTED TOMOGRAPHY;

ADMINISTRATION, INHALATION; ADULT; AEROSOL PROPELLANTS; AEROSOLS; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DRUG COMPOUNDING; FLUTICASONE; HUMANS; HYDROCARBONS, FLUORINATED; LUNG; MALE; METERED DOSE INHALERS; MIDDLE AGED; MULTIMODAL IMAGING; OROPHARYNX; PARTICLE SIZE; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84964744069     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2014.1199     Document Type: Article

References (12)

1. CDC: Centers for Disease Control and Prevention. Asthma's impact on the Nation fact sheet. http://www.cdc.gov/asthma/ompacts-nation/AsthmaFactSheet.pdf. Accessed October 23, 2012.
2. NAEPP: National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, National Heart, Lund and Blood Institute; 2007. NIH publication 07-4051.
3. Chowdhury BA, and Dal Pan G: The FDA and the safe use of long-acting beta-agonists in the treatment of asthma. N Eng J Med. 2010;362:1169-1171.
4. Martin RJ: Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol. 2002;109: S447-S460.
5. Leach CL, Colice GL, and Luskin A: Particle size of inhaled corticosteroids: Does it matter? J Allergy Clin Immunol. 2009;124:S88-S93.
6. Leach CL, Davidson PJ, and Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered dose inhaler compared with CFC-beclomethasone. Eur Res J. 1998;12:1346-1353.
7. Leach CL, Davidson PJ, Hasselquist BE, and Boudreau RJ. Lung deposition of HFA-beclomethasone is greater than that of CFC-fluticasone and CFC-beclomethasone: A crossover study in healthy volunteers. Chest. 2002;122:510-516.
8. Leach CL, Kuehl PJ, Chand R, Ketai L, Norenberg JP, and McDonald JD. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydro-fluoroalkane-134a beclomethasone in asthmatic patients. Ann Allergy Asthma Immunol. 2012;108:195-200.
9. Devadason SG, Chan HK, Haussermann S, Kietzig C, Kuehl PJ, Newman S, Sommerer K, and Taylor G: Standardization of techniques for validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products. J Aerosol Med Pulm Drug Deliv. 2012;25:S6-S9.
10. Smaldone GC, Walser L, Perry RJ, Ilowite JS, Bennett WB, and Greco M. Generation and administration of aerosols for medical and physiological research studies. J Aerosol Med. 1989;2:81-87.
11. Fleming J, Bailey D, Chan HK, Conway J, Kuehl PJ, Laube BL, and Newman S: Standardization of techniques for using single-photon emission computed tomography (SPECT) for aerosol deposition assessment of orally inhaled products. J Aerosol Med Pulm Drug Deliv. 2012;25:S29-S51.
12. Corcoran TE, Devadason SG, and Kuehl PJ: Introduction: Aerosol delivery of orally inhaled agents. J Aerosol Med Pulm Drug Deliv. 2012;25:S3-S5.